![Lisa Marie Edgar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lisa Marie Edgar
Directeur/Membre du Conseil chez
TTBSP LP
Profil
Lisa Marie Edgar is currently a Director at Top Tier Strategic Investment Fund LP and TTBSP LP.
She is also a Strategic Advisor at Open Ocean Capital Oy.
Previously, she was a Partner Emeritus at Top Tier Capital Partners LLC.
Before that, she worked as a Principal at Horsley Bridge Partners LLC and Paul Capital Partners LP.
She also worked as an Analyst at the Federal Reserve Bank of San Francisco and as a Principal at WR Hambrecht & Co. Asset Management LLC.
Ms. Edgar holds an MBA from the University of California, Berkeley and an undergraduate degree from the University of San Francisco.
Postes actifs de Lisa Marie Edgar
| Sociétés | Poste | Début |
|---|---|---|
Top Tier Capital Partners LLC
 Top Tier Capital Partners LLC Investment ManagersFinance TTCP invests in companies located across the globe. The firm targets companies operating in the fields of technology services. It provides financing for early stage and growth capital requirements. | Analyste en capital-investissement | 01/01/2003 |
Top Tier Strategic Investment Fund LP
 Top Tier Strategic Investment Fund LP Investment ManagersFinance Acts as Venture Capital Fund | Directeur/Membre du Conseil | - |
TTBSP LP
 TTBSP LP Investment ManagersFinance Functions as a venture capital fund | Directeur/Membre du Conseil | - |
Open Ocean Capital Oy
 Open Ocean Capital Oy Investment ManagersFinance Open Ocean invests in companies located in Europe. The firm targets companies operating in software sector, artificial intelligence, data-driven infrastructure, open source and automation. It provides financing for early stage transactions primarily in series A with an investment size up to EUR 6 million. It also makes follow-on investments. | Consultant / Advisor | 01/10/2022 |
Anciens postes connus de Lisa Marie Edgar
| Sociétés | Poste | Fin |
|---|---|---|
Paul Capital Partners LP
 Paul Capital Partners LP Investment ManagersFinance Paul Capital Partners' investment platforms include the Paul Capital Fund of Funds, secondary investments and commercial-stage healthcare investments. The Paul Capital Fund of Funds investment team focuses on investments in venture capital and small-cap buyouts. The firm invests in funds that support innovative products and business models. They take takes a lead investment role and actively seek advisory board seats. Their strategy is both growth and value oriented. The Paul Capital Fund of Funds venture capital investment strategy focuses on providing access to top-tier venture capital managers. The firm looks for emerging managers that have the potential to become industry leaders. They employ a multi-industry investment strategy that focuses on information technology, healthcare and clean technology. Most investments are made in early-stage companies, but some investments are made in late-stage and growth equity to provide reduced volatility and more rapid exits. The strategy is biased towards small funds and is balanced by a short list of larger funds or platforms. Paul Capital invests primarily in funds in the Silicon Valley and Boston, with growing exposure to select international investments. They make secondary investments in top tier managers obtained through the secondary market to mitigate the effect of the typical J-Curve associated with private equity fund investing. The Paul Capital Fund of Funds small-cap buyout investment strategy focuses on investments in a small-cap buyout funds in North America. They invest in small-cap buyout funds that are being raised by managers who are focused on buying companies with enterprise values of $300 million or less. To select the best performing managers, Paul Capital's process begins with a large universe of buyout relationships and ends with a focused and diversified small-cap buyout portfolio. The portfolio is complemented by co-investments and by investments in target funds obtained through the secondary market. The Paul Capital Fund of Funds co-investment strategy focuses on co-investments alongside general partners that are well-known to the firm and who require capital to close pending small-cap buyout and growth equity transactions. Investments are made directly in the securities of the portfolio company. The Fund of Funds team invests directly in portfolio companies across a full range of economic and credit cycles. For investors requiring exposure to both the firm's venture capital and small-cap buyout funds, Paul Capital provides customized solutions that allow participation in both activities over a multi-year period with a desired percentage allocation to each. Large investors seeking increased exposure to emerging managers, growth equity funds or buyout funds larger than their small-cap target (but generally less than $2 billion in size) can be accommodated through a separate account relationship. Paul Capital provides secondary transaction solutions for various sellers including pension plans, financial institutions, endowments, family offices, corporations and general partners. They help sellers reallocate their portfolio across asset types and classes, achieve early liquidity from private equity investments and obtain follow-on capital for existing portfolios and other objectives. Paul Capital Healthcare employs a variety of financing options ranging from non-dilutive financings that include royalty and revenue interest financings, to more traditional instruments such as equity and structured debt. Their clients include public and private companies, academic institutions and inventors. Paul Capital Healthcare helps companies monetize their royalty streams by selling all or a portion of these future royalties in exchange for an upfront payment and, depending on the structure, potential future payments. Paul Capital Healthcare invests in healthcare products that are approved and are generating revenue or are near commercialization. Healthcare companies should have an identifiable and established market, have patent and/or regulatory protection and be marketed by a strong organization. Paul Capital Healthcare employs the use of synthetic royalties or revenue interest financings. The firm provides a company with an upfront payment and future payments in exchange for a percentage of future product revenues. These deals are structured in a way that is similar to licensing agreements. They employ tiered revenues, reverse tiers, minimum payments, caps, step-downs and buy-out options. The deals are different from a standard licensing agreement in that Paul Capital Healthcare is not responsible for commercializing the product and is not involved in the company's daily operations. The firm makes an upfront payment to the company and, in some cases, additional payments based on certain milestones, such as regulatory approvals, patent extensions and sales targets. Paul Capital Healthcare then receives a portion of the future revenues generated by the product(s). Paul Capital Healthcare provides structured debt financing for small to mid-sized healthcare companies looking to expand operations. They can structure mezzanine-like debt in combination with revenue interests or royalty financings and the purchase of equities. Paul Capital Healthcare also structures traditional equity investments, usually in combination with revenue interest and royalty financings. The Fund participates in early-stage financing rounds in syndication with venture funds and in PIPE-style offerings. Paul Capital Healthcare focuses on near market or commercial-stage investments. | Private Equity Investor | 31/12/2005 |
WR Hambrecht & Co. Asset Management LLC
 WR Hambrecht & Co. Asset Management LLC Investment ManagersFinance WR Hambrecht seeks to deliver long-term capital gains by adhering to a consistent and disciplined investment philosophy. The firm relies heavily on internally developed quantitative research models to deliver a differentiated investment approach for the small-cap technology sector | Corporate Officer/Principal | 31/12/2001 |
Federal Reserve Bank of San Francisco
 Federal Reserve Bank of San Francisco General GovernmentGovernment Federal reserve bank | Corporate Officer/Principal | - |
Horsley Bridge Partners LLC
 Horsley Bridge Partners LLC Investment ManagersFinance Horsley Bridge Partners invests in companies located in the United States, Europe, Asia and other emerging markets. The firm focuses on the technology sectors. It provides financing for seed, early, growth and buyout transactions. | Corporate Officer/Principal | - |
Formation de Lisa Marie Edgar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Horsley Bridge Partners LLC
Horsley Bridge Partners LLC Investment ManagersFinance Horsley Bridge Partners invests in companies located in the United States, Europe, Asia and other emerging markets. The firm focuses on the technology sectors. It provides financing for seed, early, growth and buyout transactions. | Finance |
Paul Capital Partners LP
Paul Capital Partners LP Investment ManagersFinance Paul Capital Partners' investment platforms include the Paul Capital Fund of Funds, secondary investments and commercial-stage healthcare investments. The Paul Capital Fund of Funds investment team focuses on investments in venture capital and small-cap buyouts. The firm invests in funds that support innovative products and business models. They take takes a lead investment role and actively seek advisory board seats. Their strategy is both growth and value oriented. The Paul Capital Fund of Funds venture capital investment strategy focuses on providing access to top-tier venture capital managers. The firm looks for emerging managers that have the potential to become industry leaders. They employ a multi-industry investment strategy that focuses on information technology, healthcare and clean technology. Most investments are made in early-stage companies, but some investments are made in late-stage and growth equity to provide reduced volatility and more rapid exits. The strategy is biased towards small funds and is balanced by a short list of larger funds or platforms. Paul Capital invests primarily in funds in the Silicon Valley and Boston, with growing exposure to select international investments. They make secondary investments in top tier managers obtained through the secondary market to mitigate the effect of the typical J-Curve associated with private equity fund investing. The Paul Capital Fund of Funds small-cap buyout investment strategy focuses on investments in a small-cap buyout funds in North America. They invest in small-cap buyout funds that are being raised by managers who are focused on buying companies with enterprise values of $300 million or less. To select the best performing managers, Paul Capital's process begins with a large universe of buyout relationships and ends with a focused and diversified small-cap buyout portfolio. The portfolio is complemented by co-investments and by investments in target funds obtained through the secondary market. The Paul Capital Fund of Funds co-investment strategy focuses on co-investments alongside general partners that are well-known to the firm and who require capital to close pending small-cap buyout and growth equity transactions. Investments are made directly in the securities of the portfolio company. The Fund of Funds team invests directly in portfolio companies across a full range of economic and credit cycles. For investors requiring exposure to both the firm's venture capital and small-cap buyout funds, Paul Capital provides customized solutions that allow participation in both activities over a multi-year period with a desired percentage allocation to each. Large investors seeking increased exposure to emerging managers, growth equity funds or buyout funds larger than their small-cap target (but generally less than $2 billion in size) can be accommodated through a separate account relationship. Paul Capital provides secondary transaction solutions for various sellers including pension plans, financial institutions, endowments, family offices, corporations and general partners. They help sellers reallocate their portfolio across asset types and classes, achieve early liquidity from private equity investments and obtain follow-on capital for existing portfolios and other objectives. Paul Capital Healthcare employs a variety of financing options ranging from non-dilutive financings that include royalty and revenue interest financings, to more traditional instruments such as equity and structured debt. Their clients include public and private companies, academic institutions and inventors. Paul Capital Healthcare helps companies monetize their royalty streams by selling all or a portion of these future royalties in exchange for an upfront payment and, depending on the structure, potential future payments. Paul Capital Healthcare invests in healthcare products that are approved and are generating revenue or are near commercialization. Healthcare companies should have an identifiable and established market, have patent and/or regulatory protection and be marketed by a strong organization. Paul Capital Healthcare employs the use of synthetic royalties or revenue interest financings. The firm provides a company with an upfront payment and future payments in exchange for a percentage of future product revenues. These deals are structured in a way that is similar to licensing agreements. They employ tiered revenues, reverse tiers, minimum payments, caps, step-downs and buy-out options. The deals are different from a standard licensing agreement in that Paul Capital Healthcare is not responsible for commercializing the product and is not involved in the company's daily operations. The firm makes an upfront payment to the company and, in some cases, additional payments based on certain milestones, such as regulatory approvals, patent extensions and sales targets. Paul Capital Healthcare then receives a portion of the future revenues generated by the product(s). Paul Capital Healthcare provides structured debt financing for small to mid-sized healthcare companies looking to expand operations. They can structure mezzanine-like debt in combination with revenue interests or royalty financings and the purchase of equities. Paul Capital Healthcare also structures traditional equity investments, usually in combination with revenue interest and royalty financings. The Fund participates in early-stage financing rounds in syndication with venture funds and in PIPE-style offerings. Paul Capital Healthcare focuses on near market or commercial-stage investments. | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Francisco
 University of San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Federal Reserve Bank of San Francisco
Federal Reserve Bank of San Francisco General GovernmentGovernment Federal reserve bank | Government |
WR Hambrecht & Co. Asset Management LLC
WR Hambrecht & Co. Asset Management LLC Investment ManagersFinance WR Hambrecht seeks to deliver long-term capital gains by adhering to a consistent and disciplined investment philosophy. The firm relies heavily on internally developed quantitative research models to deliver a differentiated investment approach for the small-cap technology sector | Finance |
Open Ocean Capital Oy
Open Ocean Capital Oy Investment ManagersFinance Open Ocean invests in companies located in Europe. The firm targets companies operating in software sector, artificial intelligence, data-driven infrastructure, open source and automation. It provides financing for early stage transactions primarily in series A with an investment size up to EUR 6 million. It also makes follow-on investments. | Finance |
Top Tier Capital Partners LLC
Top Tier Capital Partners LLC Investment ManagersFinance TTCP invests in companies located across the globe. The firm targets companies operating in the fields of technology services. It provides financing for early stage and growth capital requirements. | Finance |
Top Tier Strategic Investment Fund LP
Top Tier Strategic Investment Fund LP Investment ManagersFinance Acts as Venture Capital Fund | Finance |
TTBSP LP
TTBSP LP Investment ManagersFinance Functions as a venture capital fund | Finance |
